Coronary Artery Anomalies and Their Impact on the Feasibility of Percutaneous Pulmonary Valve Implantation

被引:0
作者
Anja Hanser
Jörg Michel
Andreas Hornung
Ludger Sieverding
Michael Hofbeck
机构
[1] University Children’s Hospital Tuebingen,Department of Pediatric Cardiology
来源
Pediatric Cardiology | 2022年 / 43卷
关键词
Congenital heart disease; Percutaneous pulmonary valve implantation; Congenital coronary artery anomaly;
D O I
暂无
中图分类号
学科分类号
摘要
One of the major obstacles preventing successful percutaneous pulmonary valve implantation (PPVI) is related to the close proximity of coronary artery branches to the expected landing zone. The aim of this study was to assess the frequency of coronary artery anomalies (CAAs) especially those associated with major coronary branches crossing the right ventricular outflow tract (RVOT) and to describe their relevance for the feasibility of percutaneous pulmonary valve implantation (PPVI). In our retrospective single-center study 90 patients were evaluated who underwent invasive testing for PPVI in our institution from 1/2010 to 1/2020. CAAs were identified in seven patients (8%) associated with major branches crossing the RVOT due to origin of the left anterior descending (LAD) or a single coronary artery from the right aortic sinus. In 5/7 patients with CAAs balloon testing of the RVOT and selective coronary angiographies revealed a sufficiently large landing zone distal to the coronary artery branch. While unfavorable RVOT dimensions prevented PPVI in one, PPVI was performed successfully in the remaining four patients. The relatively short landing zone required application of the “folded” melody technique in two patients. All patients are doing well (mean follow-up 3 years). CAAs associated with major coronary branches crossing the RVOT can be expected in about 8% of patients who are potential candidates for PPVI. Since the LAD crossed the RVOT below the plane of the pulmonary valve successful distal implantation of the valve was possible in 4/7 patients. Therefore these coronary anomalies should not be considered as primary contraindications for PPVI.
引用
收藏
页码:8 / 16
页数:8
相关论文
共 229 条
  • [1] Cabalka AK(2017)Relationships among conduit type, pre-stenting, and outcomes in patients undergoing transcatheter pulmonary valve replacement in the prospective North American and European melody valve trials JACC Cardiovasc Interv 10 1746-1759
  • [2] Hellenbrand WE(2015)Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial Circulation 131 1960-1970
  • [3] Eicken A(2020)Percutaneous pulmonary valve implantation Korean Circ J 50 302-316
  • [4] Kreutzer J(2019)Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation Eur Heart J 40 2255-2264
  • [5] Gray RG(2014)Coronary artery compression during intention to treat right ventricle outflow with percutaneous pulmonary valve implantation: incidence, diagnosis, and outcome Catheter Cardiovasc Interv 83 E260-268
  • [6] Bergersen L(2008)Rescue surgery following percutaneous pulmonary valve implantation Eur J Cardiothorac Surg 33 607-612
  • [7] Berger F(2013)Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience Circ Cardiovasc Interv 6 535-542
  • [8] Armstrong AK(2019)Tetralogy of Fallot and abnormal coronary artery: use of a prosthetic conduit is outdated Eur J Cardiothorac Surg 56 94-100
  • [9] Cheatham JP(2005)Repair of tetralogy of Fallot with anomalous coronary arteries coursing across the obstructed right ventricular outflow tract Pediatr Cardiol 26 537-542
  • [10] Zahn EM(2011)Bilateral percutaneous pulmonary valve implantation in dual conduits from the subpulmonary ventricle to the pulmonary arteries Eur Heart J 32 2907-610